Number of dengue cases in NCR exceeds alert threshold – DOH
Maris Federez • August 16, 2019 • 723
The National Capital Region (NCR) has recorded more than 11,000 dengue cases from January to August 10 this year.
This is 33% higher than what was recorded in the past five years.
“It’s starting to rise and just like the other regions that began with the alert levels, naging epidemic level na sila [they’ve reached the epidemic level]. Pwede pa ring sumipa ang dengue. Kaya hindi ho tayo pwedeng magpahinay-hinay [Dengue case can still go up. That’s why we should not be complacent],” Department of Health (DOH) Secretary Francisco Duque said.
The cities in the NCR where dengue cases have spiked include Paranaque, Malabon, Taguig, Makati, and Mandaluyong.
The DOH clarified that no medicine, supplement, or vaccine had been proven to cure dengue.
The health department also supports the move of the Department of Science and Technology (DOST) to fund the distribution of food supplements which may help increase an individual’s platelet count to avoid dengue.
“Wala namang gamot ang dengue. Wala ring bakuna. At kung meron man sila ng inaalay na makakagamot, hindi po totoo iyan. Ito po ay food suppmement lamang at kinakailangan merong FDA certificate of product registration [There is no medicine for dengue. No vaccine either. And if there are some who offer something that’s supposed to cure dengue, it’s not true. It’s just a food supplement and it needs to have FDA certificate of product registration],” Duque added.
The health official then reminded the public to clean their surroundings and eradicate dengue-mosquito breeding areas through the 4 o’clock habit using the 4S strategy:
Search and Destroy
Seek Early Consultation
Support Space Spraying
This is to further prevent the number of dengue cases in Metro Manila to further exceed the health department’s alert threshold. (from the report of Aiko Miguel) /mbmf
The Food and Drug Administration (FDA) has ordered Department of Health (DOH)-controlled hospitals to report cases that are related to using vape.
This was after health officials in the United Stated confirmed on Tuesday (September 10) that a 50-year-old man died of lung disease linked to vape use.
According to Dr. Anton Javier, project manager of Product Research and Standards Development Division Center for Cosmetics in the FDA, they might not monitor any illnesses related to using vape just yet because of the latency period.
“Because of the latency period nga po baka po wala pa tayo makita just yet. Pwede po kasing nagve-vape ka ngayon pero iyong mga magiging sakit niyo down the line pa, (Because of the latency period, we might not see [incidence] just yet. You can actually use vape now but your illness might appear down the line)” he said.
However, an expert said the confirmed case in the United States should not be a cause of alarm.
“It’s been well proven by laboratories in the US that deaths in Kansas whatever it is, has got nothing to do with e-cigarettes its what these people has put in e cigarettes that contains adulterated contaminants of cannabis,” according to Harm Reduction Expert Dr. Tikki Pang.
The FDA had previously released a regulation on using vape or e-cigarettes. Manufacturers or retailers were given until October 25 to register their products to the FDA.
The FDA has also warned against the dangers of the chemicals found in vape products. This include cynemaldehide which causes blockage in the lungs which can lead to difficulty in breathing.
Another dangerous chemical, according to the FDA, is diacetyl which causes bronchylitis or inflammation of the lungs.—AAC (with reports from Mai Bermudez)
MANILA, Philippines – The Food and Drug Administration (FDA) is calling on hospitals under the Department of Health (DOH) to report any cases of illness or injury related to the use of electronic cigarettes (e-cigarette) and vaping amid rising number of such cases in other countries.
“The FDA requests all DOH-retained hospitals to immediately communicate relevant case reports of injuries and illnesses documented arising from the use of these devices,” the agency said in an advisory.
The FDA said this is in the interest of evidence-based policy development, and in line with the emerging report of electronic cigarette-related injury and illnesses from Europe and North America.
The agency said the use of electronic nicotine and non-nicotine delivery systems (ENDS/ENNDS) are under the purview of the agency based on Republic Act 9711, the FDA said.
“In compliance with the Data Privacy Act of 2012, it is expected that the information provided will be anonymized in as much as they are thorough and extensive,” the agency said.
As of August 27, U.S. health authorities have monitored 215 possible cases of pulmonary illnesses, all patients have reported using e-cigarette products.
According to the USCDC, e-cigarettes can contain harmful or potentially harmful substances, including nicotine, heavy metals such as lead, volatile organic compounds, and cancer-causing chemicals.
Additionally, some e-cigarette products are used to deliver illicit substances, which may be acquired from unknown or unauthorized sources.
“Based on reports from several states, patients have experienced respiratory symptoms (cough, shortness of breath, or chest pain), and some have also experienced gastrointestinal symptoms (nausea, vomiting, or diarrhea) or non-specific constitutional symptoms (fatigue, fever, or weight loss). Symptoms typically develop over a period of days but sometimes can manifest over several weeks,” the advisory stated.
The USCDC have recommended some steps for clinicians, including the reporting of cases of severe pulmonary disease of unclear etiology and history of e-cigarette use within the past 90 days, to help determine the cause of these sicknesses.
The World Health Organization (WHO) earlier said the use of e-cigarettes should be regulated as there is no evidence proving they were a safer alternative to cigarettes, warning that it normalizes smoking and hooks young people.
The Department of Science and Technology (DOST) wants to look into research-based technologies to address the dengue problem in the country.
DOST Secretary Fortunato T. de la Peña said the department has funded several research projects and programs to aid in addressing the different aspects of the disease.
“Through the DOST-Philippine Council for Health Research and Development, we have funded a number of research projects and programs consistent with the multi-prong approach in the control of dengue that address different aspects such as diagnosis and treatment,” he said.
One of the researches supported by the DOST is the Biotek M which is a rapid diagnostic test for dengue. This kit can diagnose dengue as early as two to three days after the onset of illness.
They are also looking into a possible herbal medicine for dengue.
“Dengue research and development has always been one of the priority research areas in the country. This is stated in the Harmonized National Research and Development Agenda led by the DOST,” said Sec. de la Peña.—AAC
UNTV is a major TV broadcast network with 24-hour programming. An Ultra High Frequency station with strong brand content that appeal to everyone, UNTV is one of the most trusted and successful Philippine networks that guarantees wholesome and quality viewing experience.